标题
Predictors of cardiovascular risk in familial hypercholesterolemia
作者
关键词
-
出版物
CURRENT OPINION IN LIPIDOLOGY
Volume 34, Issue 6, Pages 272-277
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2023-09-29
DOI
10.1097/mol.0000000000000903
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia
- (2023) Martine Paquette et al. Journal of Clinical Lipidology
- Association of triglyceride-glucose index with atherosclerotic cardiovascular disease and mortality among familial hypercholesterolemia patients
- (2023) Jun Wen et al. Diabetology & Metabolic Syndrome
- Risk factors for cardiovascular events in patients with heterozygous familial hypercholesterolaemia: protocol for a systematic review
- (2023) María Elena Mansilla-Rodríguez et al. BMJ Open
- A Bibliometric Analysis of Familial Hypercholesterolemia From 2011 to 2021
- (2022) Namin Wei et al. CURRENT PROBLEMS IN CARDIOLOGY
- Simple Nutrient-Based Rules vs. a Nutritionally Rich Plant-Centered Diet in Prediction of Future Coronary Heart Disease and Stroke: Prospective Observational Study in the US
- (2022) Yuni Choi et al. Nutrients
- Updates on the Use of Subclinical Atherosclerosis to Predict Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia
- (2022) Antonio Gallo et al. Current Atherosclerosis Reports
- Is the TOAST Classification Suitable for Use in Personalized Medicine in Ischemic Stroke?
- (2022) Sofie A. Simonsen et al. Journal of Personalized Medicine
- Risk of stroke in genetically verified familial hypercholesterolemia: A prospective matched cohort study
- (2022) Karianne Svendsen et al. ATHEROSCLEROSIS
- Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study
- (2022) Jonas Brinck et al. DIABETES CARE
- 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
- (2022) Donald M. Lloyd-Jones et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- World Heart Federation Cholesterol Roadmap 2022
- (2022) Kausik K. Ray et al. Global Heart
- Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease
- (2022) Berit Storgaard Hedegaard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of Current International Guidelines for the Management of Dyslipidemia
- (2022) Sevda Aygun et al. Journal of Clinical Medicine
- Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
- (2022) Chrysoula Boutari et al. Pharmaceuticals
- 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2021) Glen J. Pearson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Genetic basis of hypercholesterolemia in adults
- (2021) Seyedmohammad Saadatagah et al. npj Genomic Medicine
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
- (2021) Frank L J Visseren et al. EUROPEAN HEART JOURNAL
- Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
- (2021) Antonio J. Vallejo-Vaz et al. LANCET
- Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia
- (2021) Martine Paquette et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A resilient type of familial hypercholesterolaemia: case–control follow-up of genetically characterized older patients in the SAFEHEART cohort
- (2021) Leopoldo Pérez de Isla et al. European Journal of Preventive Cardiology
- Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care
- (2020) Gerald F. Watts et al. Nature Reviews Cardiology
- Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis
- (2020) Robert P. Giugliano et al. STROKE
- SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia
- (2020) Antonio Gallo et al. ATHEROSCLEROSIS
- Coronary Artery Calcification in Familial Hypercholesterolemia
- (2020) Reed Mszar et al. CIRCULATION
- Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia
- (2020) Gerald F. Watts et al. Heart Lung and Circulation
- Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register
- (2018) S.E. Humphries et al. ATHEROSCLEROSIS
- Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study
- (2018) Leopoldo Pérez de Isla et al. Journal of Clinical Lipidology
- The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia
- (2018) Katarina Lalić et al. ATHEROSCLEROSIS
- Diabetes is Associated with an Increased Risk of Cardiovascular Disease in Patients with Familial Hypercholesterolemia
- (2018) Martine Paquette et al. Journal of Clinical Lipidology
- Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy
- (2018) Marcio H. Miname et al. JACC-Cardiovascular Imaging
- Clinical and genetic characteristics of familial hypercholesterolemia patients with type 2 diabetes
- (2018) D. Sun et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia
- (2017) Elisenda Climent et al. Scientific Reports
- Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial HypercholesterolaemiaHighlights
- (2016) Leopoldo Pérez de Isla et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE
- (2016) Emil M. deGoma et al. Circulation-Cardiovascular Genetics
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
- (2016) Amit V. Khera et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic identification of familial hypercholesterolemia within a single U.S. health care system
- (2016) Noura S. Abul-Husn et al. SCIENCE
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE
- (2016) Emil M. deGoma et al. Circulation-Cardiovascular Genetics
- Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
- (2016) Raul D Santos et al. Lancet Diabetes & Endocrinology
- Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study
- (2015) Francisco Fuentes et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus
- (2015) Joost Besseling et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriers
- (2014) Joost Besseling et al. ATHEROSCLEROSIS
- Imaging biomarkers to track subclinical atherosclerosis in heterozygous familial hypercholesterolemia
- (2013) Marcio H Miname et al. Clinical Lipidology
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started